Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Uterus (Corpus & Uterus, NOS) (Late Stage^), 2015-2019

All Races (includes Hispanic), Female, All Ages

Sorted by Name
State
 sort alphabetically by name descending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 7.2 (7.1, 7.2) N/A 15,189 26.3
Alabama 6 4.8 (4.5, 5.1) 50 (47, 50) 163 24.2
Alaska 6 6.7 (5.5, 8.0) 28 (5, 49) 25 24.3
Arizona 6 5.9 (5.6, 6.2) 45 (34, 49) 269 25.3
Arkansas 6 6.2 (5.7, 6.7) 40 (20, 49) 124 24.9
California 3 8.0 (7.8, 8.1) 9 (6, 13) 1,873 29.6
Colorado 6 5.8 (5.4, 6.2) 46 (35, 49) 197 25.4
Connecticut 3 8.7 (8.2, 9.3) 4 (1, 10) 222 29.1
Delaware 6 8.0 (7.0, 9.0) 8 (2, 30) 57 26.6
District of Columbia 6 9.6 (8.3, 11.2) 1 (1, 13) 36 31.9
Florida 6 7.4 (7.2, 7.6) 16 (12, 21) 1,155 28.9
Georgia 3 7.8 (7.5, 8.1) 12 (6, 17) 507 32.1
Hawaii 3 9.6 (8.7, 10.6) 2 (1, 6) 89 29.8
Idaho 3 6.8 (6.1, 7.6) 22 (8, 46) 72 27.1
Illinois 3 8.0 (7.7, 8.2) 10 (5, 15) 667 26.5
Indiana 6 6.9 (6.6, 7.3) 18 (14, 36) 301 24.5
Iowa 3 6.7 (6.2, 7.3) 25 (14, 44) 143 22.3
Kansas 6 6.6 (6.0, 7.1) 31 (15, 46) 120 24.3
Kentucky 3 6.9 (6.5, 7.3) 19 (14, 39) 203 25.0
Louisiana 3 6.3 (5.9, 6.7) 38 (20, 47) 193 30.7
Maine 6 6.0 (5.4, 6.8) 43 (19, 49) 64 19.0
Maryland 6 7.8 (7.4, 8.2) 11 (5, 18) 322 28.2
Massachusetts 3 7.4 (7.0, 7.7) 15 (9, 25) 351 25.3
Michigan 6 7.6 (7.3, 7.9) 14 (7, 19) 530 26.6
Minnesota 6 6.7 (6.3, 7.1) 26 (16, 41) 242 22.0
Mississippi 6 6.5 (6.0, 7.0) 34 (17, 47) 127 27.5
Missouri 6 6.8 (6.4, 7.2) 24 (16, 39) 282 24.8
Montana 6 5.7 (5.0, 6.6) 47 (19, 50) 43 23.0
Nebraska 6 6.8 (6.2, 7.6) 21 (9, 46) 80 24.6
New Hampshire 6 6.1 (5.4, 6.9) 42 (17, 49) 60 19.9
New Jersey 3 8.6 (8.3, 8.9) 5 (2, 8) 532 27.0
New Mexico 3 7.3 (6.6, 8.0) 17 (6, 37) 101 30.1
New York 3 9.1 (8.8, 9.3) 3 (1, 5) 1,217 29.0
North Carolina 6 6.8 (6.5, 7.1) 23 (17, 37) 476 26.7
North Dakota 6 6.4 (5.4, 7.7) 36 (6, 49) 27 24.0
Ohio 6 7.6 (7.4, 7.9) 13 (7, 19) 622 24.9
Oklahoma 6 6.3 (5.8, 6.7) 39 (20, 48) 155 26.7
Oregon 6 6.5 (6.1, 7.0) 33 (18, 45) 179 21.7
Pennsylvania 6 8.1 (7.8, 8.4) 6 (4, 14) 748 24.8
Puerto Rico 6 6.6 (6.1, 7.1) N/A 142 21.9
Rhode Island 6 6.7 (5.9, 7.6) 27 (7, 48) 50 23.2
South Carolina 6 6.0 (5.6, 6.3) 44 (30, 49) 214 26.3
South Dakota 6 5.6 (4.8, 6.6) 48 (20, 50) 33 21.7
Tennessee 6 6.2 (5.8, 6.5) 41 (26, 48) 277 24.4
Texas 3 6.5 (6.3, 6.6) 35 (24, 41) 1,008 27.2
Utah 3 6.6 (6.0, 7.2) 30 (15, 47) 96 24.9
Vermont 6 6.5 (5.5, 7.7) 32 (6, 49) 31 19.4
Virginia 6 6.4 (6.1, 6.7) 37 (21, 45) 354 25.1
Washington 5 6.6 (6.2, 6.9) 29 (18, 43) 305 24.5
West Virginia 6 6.9 (6.2, 7.5) 20 (11, 44) 94 21.0
Wisconsin 6 8.0 (7.6, 8.4) 7 (4, 16) 317 25.5
Wyoming 6 5.1 (4.1, 6.3) 49 (24, 50) 19 22.5
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 05/28/2023 7:48 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
3 Source: SEER November 2021 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2021 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top